These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33128657)

  • 41. Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease.
    Assaf AR; Lapane KL; McKenney JL; Carleton RA
    N Engl J Med; 1993 Sep; 329(13):931-5. PubMed ID: 8361508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug use in relation to clinical activities as an instrument for prospective drug budgeting. The Belgian experience.
    Closon MC; Crott R; Even-Adin D
    Pharmacoeconomics; 1996 Mar; 9(3):246-63. PubMed ID: 10160100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alternative methods of hospital remuneration in Israel.
    Ginsberg G; Penchas S; Israeli A
    Isr J Med Sci; 1991 Oct; 27(10):583-9. PubMed ID: 1955316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Effect of Diagnosis-Related Group Payment System on Quality of Care in the Field of Obstetrics and Gynecology among Korean Tertiary Hospitals.
    Jung YW; Pak H; Lee I; Kim EH
    Yonsei Med J; 2018 Jun; 59(4):539-545. PubMed ID: 29749137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do hospitals respond to changing incentive structures? Evidence from Medicare's 2007 DRG restructuring.
    Cook A; Averett S
    J Health Econ; 2020 Sep; 73():102319. PubMed ID: 32653652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathways to DRG-based hospital payment systems in Japan, Korea, and Thailand.
    Annear PL; Kwon S; Lorenzoni L; Duckett S; Huntington D; Langenbrunner JC; Murakami Y; Shon C; Xu K
    Health Policy; 2018 Jul; 122(7):707-713. PubMed ID: 29754969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis related group 'all payor' hospital payment and medical diseases. Financial risk and hospital cost in medical noncomplicating condition-stratified diagnosis related groups.
    Muñoz E; Goldstein J; Benacquista T; Mulloy K; Wise L
    Arch Intern Med; 1989 Feb; 149(2):417-20. PubMed ID: 2492795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pilot results of 47 148 cases of BJ-DRGs-based payment in China.
    Zeng JQ
    Int J Health Plann Manage; 2019 Oct; 34(4):1386-1398. PubMed ID: 31286577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Defining the 90-day cost structure of lower extremity revascularization for alternative payment model assessment.
    Duwayri YM; Aiello FA; Tracci MC; Nedza S; Ryan PC; Adams JG; Shutze WP; Lum YW; Woo K
    J Vasc Surg; 2021 Feb; 73(2):662-673.e3. PubMed ID: 32652115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Price Changes in Regulated Healthcare Markets: Do Public Hospitals Respond and How?
    Verzulli R; Fiorentini G; Lippi Bruni M; Ugolini C
    Health Econ; 2017 Nov; 26(11):1429-1446. PubMed ID: 27785849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Change in MS-DRG assignment and hospital reimbursement as a result of Centers for Medicare & Medicaid changes in payment for hospital-acquired conditions: is it coding or quality?
    McNutt R; Johnson TJ; Odwazny R; Remmich Z; Skarupski K; Meurer S; Hohmann S; Harting B
    Qual Manag Health Care; 2010; 19(1):17-24. PubMed ID: 20042930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of DRG payment on New Jersey hospitals.
    Hsiao WC; Dunn DL
    Inquiry; 1987; 24(3):212-20. PubMed ID: 2958411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do diagnosis-related group-based payments incentivise hospitals to adjust output mix?
    Liang LL
    Health Econ; 2015 Apr; 24(4):454-69. PubMed ID: 24519749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Illness-based payment to hospitals: the French experience].
    De Pouvourville G; Comar L; Bouvier V
    Rev Epidemiol Sante Publique; 1994; 42(1):68-78. PubMed ID: 8134668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Case mix based payment and DPC from an international perspective].
    Matsuda S
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1152-7. PubMed ID: 15332535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pediatric patients, DRG hospital payment, and comorbidities.
    Munoz E; Lory M; Josephson J; Goldstein J; Brewster J; Wise L
    J Pediatr; 1989 Oct; 115(4):545-8. PubMed ID: 2507766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Payment of hospital cardiac services.
    Unger WJ
    Hosp Technol Ser; 1991; 10(26):1-148. PubMed ID: 10115896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Buying efficiency: optimal hospital payment in the presence of double upcoding.
    Spika SB; Zweifel P
    Health Econ Rev; 2019 Dec; 9(1):38. PubMed ID: 31884524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A trial of prospective payment system (DRGs/PPS) in Sendai National Hospital].
    Yamauchi H
    Rinsho Byori; 2000 Mar; 48(3):256-60. PubMed ID: 10804835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Payment policy for chemotherapy in public hospitals: a case for splitting DRG 780/R63Z.
    Duckett SJ; Stow S
    Aust N Z J Public Health; 2001 Dec; 25(6):552-5. PubMed ID: 11824994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.